Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance
Microbial Pathogenesis · 2025-04 · 201 · 107317
DOI: 10.1016/j.micpath.2025.107317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2025-04. Verfasst von Seyyed Mohammad Javad Mousavi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Gram-Negative Bacteria, Drug Resistance, Bacterial. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 167 Literaturangaben.
Abstract (Originalsprache)
Following a period of disuse owing to the emergence of multidrug-resistant Gram-negative bacteria, colistin has regained global attention as an antibiotic of last resort. The resurgence in its utilization has led to a concurrent increase in acquired resistance, presenting a significant challenge in clinical treatment. Predominantly, resistance mechanisms involve alterations in the lipid A component of the lipopolysaccharide (LPS) structure. These alterations are facilitated by the addition of cationic phosphoethanolamine (pEtN) or 4-amino-L-arabinose, often driven by the upregulation of two-component regulatory systems such as PmrAB and PhoPQ. Structural components of bacteria, such as capsules and efflux pumps, can also play an important role in the resistance mechanism. In addition to these biochemical modifications, structural components of bacteria like capsules and efflux pumps also play crucial roles in mediating resistance. Another significant mechanism is the acquisition of the plasmid-mediated mobilized colistin resistance (mcr) gene, which poses a global health threat due to its ability to transfer between different bacterial genera. Contemporary strategies to combat colistin resistance include the development and use of novel drugs and inhibitors. To devise effective interventions, it is imperative to first elucidate the precise mechanisms of colistin resistance and determine the roles of various contributing factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, Virology and Microbial Toxins, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
- Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
- Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Mousavi, S. M. J., Hosseinpour, M., Kodori, M., Rafiei, F., Mahmoudi, M., Shahraki, H., Shiri, H., Hashemi, A., & Sharahi, J. Y. (2025). Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance. Microbial Pathogenesis, 201, 107317. https://doi.org/10.1016/j.micpath.2025.107317
Vancouver
Mousavi SMJ, Hosseinpour M, Kodori M, Rafiei F, Mahmoudi M, Shahraki H, et al. Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance. Microbial Pathogenesis. 2025;201:107317. doi:10.1016/j.micpath.2025.107317
BibTeX
@article{Mousavi2025,
author = {Mousavi, Seyyed Mohammad Javad and Hosseinpour, Minoo and Kodori, Mansoor and Rafiei, Fariba and Mahmoudi, Mohammad and Shahraki, Hojat and Shiri, Hamidreza and Hashemi, Ali and Sharahi, Javad Yasbolaghi},
title = {Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance},
journal = {Microbial Pathogenesis},
year = {2025},
volume = {201},
pages = {107317},
doi = {10.1016/j.micpath.2025.107317}
}
EUVIMED